Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,736.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 2,774.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 30,232
  • Market Cap: £1,146.31m
  • RiskGrade: 128

Genus cuts full-year profit outlook

By Michele Maatouk

Date: Tuesday 16 May 2023

LONDON (ShareCast) - (Sharecast News) - Animal genetics company Genus cut its full-year profit outlook on Tuesday as it pointed to "very challenging" market conditions in the porcine business in China.
The porcine genetics business in China is now expected to be modestly loss-making in the second half of the year, versus a profit of £8.8m in the first half. As a result, full-year pre-tax profit is set to be lower than the company previously expected.

Genus noted that market researchers are currently expecting a recovery in the China porcine market in the summer as the supply decreases and consumer demand for pork continues to increase, but said there is uncertainty as to the timing of when the demand for porcine genetics will improve.

In an update for the four months to 30 April, Genus said that with the exception of China, it achieved "good trading" in its porcine business, with strong volume and royalty revenue growth, and good operating profit growth.

North America, Latin America and Europe all delivered strong growth in operating profit, it said, while Asia saw a drop in operating profit due to the performance in China.

"Since December 2022 the Chinese porcine market has been weak, reflecting high supply of slaughter pigs following widespread African Swine Fever ('ASF')," it said.

Expectations of a recovery in the market grew in February, when the pig price rose. However, since then the pig price has fallen back below 15 RMB/kg, with continued widespread ASF outbreaks and subdued demand.

"At these prices, producers are unprofitable, and many are not replacing and rebuilding their sow herds at the current time. Due to the volatile porcine market PIC China's trading has been weaker than the first half of the fiscal year, achieving lower revenues, with operating profit also impacted by costs associated with the clearance of inventory at two PIC farms that were infected by ASF in the period."

At 0815 BST, the shares were down 10% at 2,308p.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,736.00p
Change Today 32.00p
% Change 1.88 %
52 Week High 2,774.00
52 Week Low 1,637.00
Volume 30,232
Shares Issued 66.03m
Market Cap £1,146.31m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.12% below the market average95.12% below the market average95.12% below the market average95.12% below the market average95.12% below the market average
96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average96.08% below the sector average
Price Trend
59.59% below the market average59.59% below the market average59.59% below the market average59.59% below the market average59.59% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Income
84.98% below the market average84.98% below the market average84.98% below the market average84.98% below the market average84.98% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
68.65% below the market average68.65% below the market average68.65% below the market average68.65% below the market average68.65% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 26-Apr-2024

Time Volume / Share Price
17:06 600 @ 1,736.00p
16:35 8,131 @ 1,736.00p
16:35 1 @ 1,736.00p
16:35 86 @ 1,736.00p
16:35 42 @ 1,736.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page